HIGHFDA DRUG

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
May 27, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
May 27, 2026
Hazard Level
HIGH
Brands
ARIPIPRAZOLE, Ajanta Pharma USA Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
ARIPIPRAZOLE, Ajanta Pharma USA Inc.
Model numbers
Lot: PA00805, expires: 01/31/2029
UPC codes
27241-051, 27241-052, 27241-053, 27241-054, 27241-055, 27241-056, 27241-051-03, 27241-051-08 +8 more
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    May 27, 2026

  2. Reported by FDA DRUG

    June 24, 2026

  3. RecallRadar source check

    June 30, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Ajanta Pharma USA Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for ARIPIPRAZOLE recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.. Generic: ARIPIPRAZOLE; Brand: ARIPIPRAZOLE. Reason: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.. Classification: Class II. Quantity: 6,143 bottles. Distribution: U.S. Nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot: PA00805
expires: 01/31/2029
UPC Codes
27241-051
27241-052
27241-053
+13 more
Affected States
ALL
Report Date
June 24, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls